Newsmaker - Michael Redman

Bone Medical Limited has appointed Michael Redman as chairman, replacing Michael Perrot who has become a non-executive director. Immediately prior to Bone Medical, Mr Redman was the chief executive officer and co-founder of Opexa Pharmaceuticals, which commenced operations in February 2001 and was successfully sold to PharmaFrontiers in November of 2004. His career combines sales, marketing, business and commercial development experience gained over 25 years in the pharmaceuticals and biotechnology industry. Prior to Opexa, Mr Redman held key management positions with US-based firms: Zonagen, Aronex Pharmaceuticals, Biovail, and American Home Products. He is an active member of the Licensing Executives Society and formerly served on its executive committee.

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
10th-The University of Notre Dame Australia6,708
47 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer